BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33389296)

  • 21. Clinical implications of uncertain resection in scenarios of metastasis of the highest or most distant mediastinal lymph node station following surgical treatment of non-small-cell lung cancer.
    Park SY; Byun GE; Lee CY; Lee JG; Kim DJ; Paik HC; Chung KY
    Lung Cancer; 2019 Dec; 138():1-5. PubMed ID: 31593893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative radiotherapy option based on mediastinal lymph node reclassification for patients with pN2 non-small-cell lung cancer.
    Jin J; Xu Y; Hu X; Chen M; Fang M; Hang Q; Chen M
    Curr Oncol; 2020 Jun; 27(3):e283-e293. PubMed ID: 32669935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N2 lung cancer is not all the same: an analysis of different prognostic groups.
    Bertoglio P; Ricciardi S; Alì G; Aprile V; Korasidis S; Palmiero G; Fontanini G; Mussi A; Lucchi M
    Interact Cardiovasc Thorac Surg; 2018 Nov; 27(5):720-726. PubMed ID: 29788107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
    O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
    Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of the relationship between the anatomical location of intrapulmonary metastatic lymph nodes and relapse risk and survival in patients with N1 non-small cell lung cancer].
    Zhao DC; Yan S; Wang YQ; Ma YY; Wang X; Li SL; Li X; Lyu C; Wang YZ; Wang J; Yang Y; Wu N
    Zhonghua Yi Xue Za Zhi; 2021 Sep; 101(35):2778-2786. PubMed ID: 34551494
    [No Abstract]   [Full Text] [Related]  

  • 27. [A modified pathological N1 classification strategy based on the systematic dissection of N1 nodes for non-small cell lung cancer].
    Yan S; Wu N
    Zhonghua Yi Xue Za Zhi; 2021 Sep; 101(35):2748-2750. PubMed ID: 34551490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of the N1 classification pattern: a meta-analysis of different subclassification methods.
    Wang Z; Yang H; Hao X; Zhou J; Chen N; Pu Q; Liu L
    Eur J Cardiothorac Surg; 2021 Apr; 59(3):545-553. PubMed ID: 33253363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Prognostic Significance of Metastasis to Lymph Nodes in Aortopulmonary Zone (Stations 5 and 6) in Completely Resected Left Upper Lobe Tumors.
    Citak N; Sayar A; Metin M; Büyükkale S; Kök A; Solak O; Yurt S; Gürses A
    Thorac Cardiovasc Surg; 2015 Oct; 63(7):568-76. PubMed ID: 25893919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors for Occult Lymph Node Metastasis in Peripheral Non-Small Cell Lung Cancer with Invasive Component Size 3 cm or Less.
    Moon Y; Choi SY; Park JK; Lee KY
    World J Surg; 2020 May; 44(5):1658-1665. PubMed ID: 31912252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer.
    Saji H; Tsuboi M; Shimada Y; Kato Y; Yoshida K; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Chest; 2013 Jun; 143(6):1618-1625. PubMed ID: 23740149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of the number of positive lymph nodes in resected non-small cell lung cancer.
    Fukui T; Mori S; Yokoi K; Mitsudomi T
    J Thorac Oncol; 2006 Feb; 1(2):120-5. PubMed ID: 17409840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Implication of N1b Classification in the Eighth Edition of the Tumor-Node-Metastasis Staging System of Differentiated Thyroid Cancer.
    Kim M; Jeon MJ; Oh HS; Park S; Song DE; Sung TY; Kim TY; Chung KW; Kim WB; Shong YK; Lee YM; Kim WG
    Thyroid; 2018 Apr; 28(4):496-503. PubMed ID: 29620964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
    Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colon Neuroendocrine Tumors: A New Lymph Node Staging Classification.
    Fields AC; McCarty JC; Lu P; Vierra BM; Pak LM; Irani J; Goldberg JE; Bleday R; Chan J; Melnitchouk N
    Ann Surg Oncol; 2019 Jul; 26(7):2028-2036. PubMed ID: 30927196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
    Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
    Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Importance of the Lymph Node Factor in Surgically Resected Non-Small Cell Lung Cancer.
    Tezel C; Dogruyol T; Alpay L; Akyıl M; Evman S; Metin S; Baysungur V; Yalcinkaya I
    Thorac Cardiovasc Surg; 2020 Mar; 68(2):183-189. PubMed ID: 30388719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beyond Margin Status: Population-Based Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification Recategorization.
    Osarogiagbon RU; Faris NR; Stevens W; Fehnel C; Houston-Harris C; Ojeabulu P; Akinbobola OA; Lee YS; Ray MA; Smeltzer MP
    J Thorac Oncol; 2020 Mar; 15(3):371-382. PubMed ID: 31783180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.